Related Experiment Videos
Clinical significance of hepatitis C virus genotypes and quasispecies
1Department of Medical Sciences, University of Cagliari, Italy. farcip@pacs.unica.it
Insights
Hepatitis C virus (HCV) exhibits significant genetic variability, circulating as a quasispecies. This viral diversity impacts persistence, drug resistance, and vaccine development, influencing chronic HCV infection outcomes.
Area of Science:
- Virology
- Immunology
- Genetics
Background:
- Hepatitis C virus (HCV) infection leads to chronic disease in 85% of cases despite immune responses.
- HCV possesses high genetic variability due to its error-prone replication, forming quasispecies.
- This variability is structured hierarchically into genotypes, subgenotypes, isolates, and quasispecies.
Purpose of the Study:
- To review the current understanding of the biological and clinical implications of Hepatitis C virus genetic variability.
- To explore the impact of HCV genotypes and quasispecies on disease natural history, transmission, and pathogenesis.
- To discuss the role of viral genetic diversity in immune escape, antiviral resistance, and vaccine development.
Main Methods:
- Literature review of studies on Hepatitis C virus genetic variability.
- Analysis of data concerning the influence of HCV genotypes and quasispecies on clinical outcomes.
- Synthesis of evidence on the biological mechanisms underlying HCV genetic diversity and its clinical relevance.
Main Results:
- HCV genotypes may influence antiviral therapy outcomes, but their role in disease natural history and pathogenesis is not fully understood.
- HCV circulates as a quasispecies, a diverse population of viral genomes.
- The quasispecies nature of HCV provides a reservoir of variants crucial for viral persistence, immune evasion, and drug resistance.
Conclusions:
- HCV's genetic variability, particularly its quasispecies nature, has significant clinical implications.
- Understanding HCV genetic diversity is essential for managing chronic infection, developing effective treatments, and designing vaccines.
- Further research is needed to fully elucidate the clinical significance of HCV genotypes and quasispecies.
Abstract:
Hepatitis C virus (HCV) is a major cause of morbidity and mortality worldwide. The infection becomes chronic in about 85% of infected individuals, in the face of a strong humoral and cellular immune response. One of the most important features of HCV is its high degree of genetic variability, which is due to the inherent low fidelity of the viral replication machinery. As a consequence, HCV circulates in vivo as a population of divergent, albeit closely related, genomes exhibiting a distribution that follows the model referred to as a quasispecies. The genetic variability of HCV is complex and has been classified into four hierarchical strata: genotypes, subgenotypes, isolates, and quasispecies. Over the past few years, an extraordinary interest has been focused on the biologic and clinical implications of the genetic variability of HCV. Although there is consensus that the genotypes may influence the out come of antiviral therapy, their clinical significance in the natural history of the disease, as well as in transmission, infectivity, and pathogenesis of HCV infection, remains elusive. Conversely, evidence has accumulated that the quasispecies nature of HCV provides a large reservoir of biologically different viral variants that may have important clinical implications for viral persistence by immune escape mechanisms, for the generation of antiviral drug resistance, and for the development of an effective vaccine. This article reviews the state of the art on the biologic and clinical implications of the genetic variability of HCV.